D Rana1,2, B Bellflower1,2, J Sahni3, A J Kaplan1, N T Owens1, E L Arrindell1,2, A J Talati1,2, R Dhanireddy1,2. 1. Division of Neonatal Medicine, Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN, USA. 2. Le Bonheur Children's Hospital, Memphis, TN, USA. 3. Department of Clinical Pharmacy, Le Bonheur Children's Hospital, Memphis, TN, USA.
Abstract
OBJECTIVE: To assess the opioid and benzodiazepine usage in a level IV NICU after implementation of pain guidelines. STUDY DESIGN: Guidelines were developed for infants undergoing surgical procedures and infants on mechanical ventilation. Data collected for period 1 (July to December 2013) and period 2 (March to August 2014). RESULTS: Gestational age, birth weight and infants with hypoxic respiratory failure or requiring major procedures were comparable in two periods. Number of patients exposed to opioids decreased from 62.9% (129/205) in period 1 to 32.8% (82/250) in period 2, P=<0.001. Cumulative dose exposure decreased, opioids in morphine equivalent dose, mg kg-1 (1.64 (0.38 to 6.94) vs 0.51 (0.04 to 2.33), P=0.002), sedatives in midazolam equivalent, mg kg-1 (0.16 (0.03 to 7.39) vs 0.10 (0.00 to 4.00), P=0.03). Ten patients required treatment for iatrogenic opioid withdrawal versus only three in post guideline, P=0.02. CONCLUSIONS: Evidence-based guidelines led to significant reduction in opioids and sedatives exposure, and in the number of infants requiring methadone for iatrogenic narcotic dependence.
OBJECTIVE: To assess the opioid and benzodiazepine usage in a level IV NICU after implementation of pain guidelines. STUDY DESIGN: Guidelines were developed for infants undergoing surgical procedures and infants on mechanical ventilation. Data collected for period 1 (July to December 2013) and period 2 (March to August 2014). RESULTS: Gestational age, birth weight and infants with hypoxic respiratory failure or requiring major procedures were comparable in two periods. Number of patients exposed to opioids decreased from 62.9% (129/205) in period 1 to 32.8% (82/250) in period 2, P=<0.001. Cumulative dose exposure decreased, opioids in morphine equivalent dose, mg kg-1 (1.64 (0.38 to 6.94) vs 0.51 (0.04 to 2.33), P=0.002), sedatives in midazolam equivalent, mg kg-1 (0.16 (0.03 to 7.39) vs 0.10 (0.00 to 4.00), P=0.03). Ten patients required treatment for iatrogenic opioid withdrawal versus only three in post guideline, P=0.02. CONCLUSIONS: Evidence-based guidelines led to significant reduction in opioids and sedatives exposure, and in the number of infants requiring methadone for iatrogenic narcotic dependence.
Authors: K J S Anand; R Whit Hall; Nirmala Desai; Barbara Shephard; Lena L Bergqvist; Thomas E Young; Elaine M Boyle; Ricardo Carbajal; Vinod K Bhutani; Mary Beth Moore; Shari S Kronsberg; Bruce A Barton Journal: Lancet Date: 2004-05-22 Impact factor: 79.321
Authors: David F Grabski; Rick D Vavolizza; Sarah Lepore; Daniel Levin; Sara K Rasmussen; Jonathan R Swanson; Eugene D McGahren; Jeffrey W Gander Journal: Pediatrics Date: 2020-11-12 Impact factor: 7.124
Authors: Hanna Popowicz; Katarzyna Kwiecień-Jaguś; Jolanta Olszewska; Wioletta A Mędrzycka-Dąbrowska Journal: J Pain Res Date: 2020-07-24 Impact factor: 3.133
Authors: Hana Cihlarova; Lenka Bencova; Blanka Zlatohlavkova; Karel Allegaert; Pavla Pokorna Journal: Front Pediatr Date: 2022-06-23 Impact factor: 3.569